TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Nattopharma AS
Closing information (x1000 DKK)
| Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Turnover |
129,017
|
161,134
|
151,733 |
| Financial expenses |
-104,925
|
723
|
-14,614 |
| Earnings before taxes |
108,570
|
-8,612
|
31,167 |
| Total assets |
194,029
|
170,740
|
180,894 |
| Current assets |
142,401
|
95,682
|
88,791 |
| Current liabilities |
126,687
|
55,794
|
46,964 |
| Equity capital |
65,270
|
107,737
|
128,701 |
| - share capital |
44,584
|
47,056
|
42,116 |
Financial ratios
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Solvency |
33.6%
|
63.1%
|
71.1% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
84.2%
|
-5.3%
|
20.5% |
| Return on assets (ROA) |
1.9%
|
-4.6%
|
9.2% |
| Current ratio |
112.4%
|
171.5%
|
189.1% |
| Return on equity (ROE) |
166.3%
|
-8.0%
|
24.2% |
| Change turnover |
-23,654
|
1,226
|
58,946 |
| Change turnover % |
-15%
|
1%
|
64% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.